1. Home
  2. PGEN vs GILT Comparison

PGEN vs GILT Comparison

Compare PGEN & GILT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PGEN
  • GILT
  • Stock Information
  • Founded
  • PGEN 1998
  • GILT 1987
  • Country
  • PGEN United States
  • GILT Israel
  • Employees
  • PGEN N/A
  • GILT N/A
  • Industry
  • PGEN Biotechnology: Pharmaceutical Preparations
  • GILT Radio And Television Broadcasting And Communications Equipment
  • Sector
  • PGEN Health Care
  • GILT Technology
  • Exchange
  • PGEN Nasdaq
  • GILT Nasdaq
  • Market Cap
  • PGEN 292.6M
  • GILT 281.1M
  • IPO Year
  • PGEN N/A
  • GILT 1993
  • Fundamental
  • Price
  • PGEN $0.78
  • GILT $6.09
  • Analyst Decision
  • PGEN Buy
  • GILT Strong Buy
  • Analyst Count
  • PGEN 5
  • GILT 2
  • Target Price
  • PGEN $7.00
  • GILT $8.50
  • AVG Volume (30 Days)
  • PGEN 905.3K
  • GILT 420.3K
  • Earning Date
  • PGEN 11-14-2024
  • GILT 11-13-2024
  • Dividend Yield
  • PGEN N/A
  • GILT N/A
  • EPS Growth
  • PGEN N/A
  • GILT 17.04
  • EPS
  • PGEN N/A
  • GILT 0.29
  • Revenue
  • PGEN $3,963,000.00
  • GILT $302,932,000.00
  • Revenue This Year
  • PGEN N/A
  • GILT $18.81
  • Revenue Next Year
  • PGEN $426.76
  • GILT $32.32
  • P/E Ratio
  • PGEN N/A
  • GILT $21.09
  • Revenue Growth
  • PGEN N/A
  • GILT 15.14
  • 52 Week Low
  • PGEN $0.76
  • GILT $4.04
  • 52 Week High
  • PGEN $1.93
  • GILT $6.73
  • Technical
  • Relative Strength Index (RSI)
  • PGEN 39.38
  • GILT 67.53
  • Support Level
  • PGEN $0.76
  • GILT $5.40
  • Resistance Level
  • PGEN $0.97
  • GILT $6.40
  • Average True Range (ATR)
  • PGEN 0.07
  • GILT 0.23
  • MACD
  • PGEN -0.01
  • GILT 0.07
  • Stochastic Oscillator
  • PGEN 7.90
  • GILT 74.59

About PGEN Precigen Inc.

Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

About GILT Gilat Satellite Networks Ltd.

Gilat Satellite Networks Ltd is a provider of satellite-based broadband communications. The company designs and manufactures ground-based satellite communications equipment and provides comprehensive solutions and end-to-end services. Its portfolio includes a cloud-based satellite network platform, very small aperture terminals (VSATs), amplifiers, high-speed modems, on-the-move antennas and high-power solid-state power amplifiers (SSPAs), block-up converters (BUCs) and Transceivers. The company's solutions support multiple applications with a full portfolio of products to address key applications including broadband access, cellular backhaul, enterprise, in-flight connectivity, maritime, trains, defense, and public safety.

Share on Social Networks: